Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.

At this stage of life, it's vital to lift weights, avoid getting too thin, reduce alcohol and keep up to date with jabs ...

A copy of the Company’s presentation will be available under the Presentations tab of the Tonix website at https://ir.tonixpharma.com/presentations.

FDA approval based on superiority of Gazyva over standard therapy alone, as shown in Phase II NOBILITY and Phase III REGENCY data –– Gazyva is the only anti-CD20 monoclonal antibody to demonstrate a ...

A common urinary tract infection turned life-threatening for 31-year-old Lauren Carson. What began as mild discomfort ...

An almost 70-year-old patient came to see me complaining that her antidepressant medication was no longer effective at its ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Affordable, familiar and easy to find in supermarkets, Felix is a household name for lots of cat owners. It offers food for ...

New WHO data shows catastrophic failure rates for essential medicines, threatening to reverse decades of medical progress ...

LEO Pharma A/S, a global leader in medical dermatology, is advancing the understanding of skin disease and its impact on patients' lives with the presentation of 46 abstracts at the upcoming 2025 Fall ...

A urinary tract infection, or UTI, means that bacteria have entered the urinary system and spread somewhere from the urethra to the bladder or even up to the kidneys. Symptoms usually include pain ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...